Back to Journals » Clinical Interventions in Aging » Volume 15

The Effect of Theracurmin on Cognitive Function in an Older Patient with Chemobrain

Authors Erken N, Dost Gunay FS, Soysal P, Isik AT

Received 3 March 2020

Accepted for publication 29 April 2020

Published 19 May 2020 Volume 2020:15 Pages 691—693

DOI https://doi.org/10.2147/CIA.S252229

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Richard Walker


Neziha Erken,1 Fatma Sena Dost Gunay,1 Pinar Soysal,2 Ahmet Turan Isik1

1Department of Geriatric Medicine, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey; 2Department of Geriatric Medicine, Bezmialem Vakif University, Faculty of Medicine, Istanbul, Turkey

Correspondence: Ahmet Turan Isik
Unit for Brain Aging and Dementia, Department of Geriatric Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey Tel +90 232 412 43 41
Fax +90 232 412 43 49
Email atisik@yahoo.com

Abstract: Chemobrain is one of the problems that may arise during or after treatment and there is currently no specific treatment for this condition. Our case was a 76-year-old female patient who presented to our clinic with complaints of forgetfulness that did not affect daily living activities for the last year. Breast cancer was diagnosed in 2013 and she has been receiving anastrozole treatment for 6 years after local mass excision surgery and radiotherapy. After a comprehensive geriatric evaluation, cognitive impairment due to systemic cancer therapy was detected and treatment was started with Theracurmin 90 mg twice a day therapy. After 3-months of Theracurmin therapy, she had no cognitive improvement during the follow-up. This case report demonstrated that Theracurmin treatment may be a new option for chemobrain.

Keywords: chemobrain, Theracurmin, elderly, cognitive impairment, cancer

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]